Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (Q33488674)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group |
scientific article |
Statements
1 reference
Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group (English)
1 reference
A Santoro
1 reference
H Mouridsen
1 reference
J Verweij
1 reference
W Steward
1 reference
R Somers
1 reference
J Buesa
1 reference
P Casali
1 reference
D Spooner
1 reference
E Rankin
1 reference
1 July 1995
1 reference
1 reference
1537-1545
1 reference
Identifiers
1 reference
1 reference